Product Theater:
Imbria Pharmaceuticals

WHEN: Fri, Oct 23 // 7:15 am - 8:15 am (ET)

IN-PERSON: Seaport Ballroom (Mezzanine / Level 2)
LIVESTREAM: Yes | ON-DEMAND: No

Targeting Cardiac Energetics in Non-obstructive HCM: From Rationale to Clinical EvidenceT

Could targeting cardiac energy metabolism improve symptoms and exercise capacity in non-obstructive HCM? This session explores the rationale for ninerafaxstat, an investigational cardiac mitotrope, its published clinical findings and the questions being tested in an ongoing global Phase 2b trial.

Speaker:

Arash Yavari, MBBS, DPhil
Chief Scientific Officer, Imbria Pharmaceuticals

BACK TO MAIN PRODUCT THEATERS PAGE